Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 28, 2015 9:11 PM ET

Pharmaceuticals

Company Overview of Cambridge Major Laboratories, Inc.

Company Overview

Cambridge Major Laboratories, Inc. provides active pharmaceutical ingredient (API) development and manufacturing services. It provides services from concept to commercialization to supply APIs; process chemistry solutions; and process research services aimed at scouting alternate routes to existing molecules. The company also provides solid state chemistry services, which include crystallization study, material characterization, solubility determination, salt selection, polymorph study, crystallization process development, and crystal habit optimization. Cambridge Major Laboratories, Inc. was formerly known as Cambridge Chemical Inc. and changed its name to Cambridge Major Laboratories, Inc....

W130 N10497 Washington Drive

Germantown, WI 53022

United States

Phone:

262-251-5044

Fax:

262-251-5577

Key Executives for Cambridge Major Laboratories, Inc.

Chief Executive Officer
Age: 50
Founder, Non-Executive Chairman and Scientific Advisor
Chief Financial Officer
President of Cml Europe
Chief Information Officer and Vice President of Information Technology
Compensation as of Fiscal Year 2015.

Cambridge Major Laboratories, Inc. Key Developments

AAIPharma Services and Cambridge Major Laboratories Announce Manufacturing Agreement for Atossa's Afimoxifene Gel

Atossa Genetics Inc. announced that it has signed manufacturing and quality agreements with AAIPharma Services Corp. /Cambridge Major Laboratories, Inc. (AAI/CML) for the manufacturing of a clinical supply for 4-Hydroxytamoxifen, the active pharmaceutical ingredient (API) in Atossa's lead drug candidate, Afimoxifene Gel. In May 2015, Atossa acquired from Besins Healthcare the exclusive rights to Afimoxifene Gel for the potential treatment of hyperplasia of the breast.

CML - AAI Pharma Presents at BIO-Europe Spring 2015, Mar-09-2015

CML - AAI Pharma Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

Cambridge Major Laboratories Inc. Announces More Than $20 Million Expansion of its Germantown Facility

Cambridge Major Laboratories Inc. has received an incentive package from state and local governments worth as much as $2 million as part of a more than $20 million expansion of its Germantown facility. The expansion is expected to create more than 75 jobs during the next three years. Cambridge Major's expansion will include a new administrative headquarters, as well as additions to its research and development and manufacturing capacity. The expansion is scheduled to be completed by the end of 2015.

Similar Private Companies By Industry

Company Name Region
Mnemosyne Pharmaceuticals, Inc. United States
Viral Oncotherapies, Inc United States
SanoGene Therapeutics Inc. United States
TSI Health Sciences, Inc. United States
Pedinol Pharmacal, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cambridge Major Laboratories, Inc., please visit www.c-mlabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.